Christopher Dean

2.0k citations

78 papers · 1.6k indexed · h-index 24

Impact in

Radiology, Nuclear Medicine and Imaging top 2%
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
Oncology top 5%
- HER2/EGFR in Cancer Research

Papers in ⓘ

Radiology, Nuclear Medicine and Imaging 54
- Monoclonal and Polyclonal Antibodies Research 44
- Radiopharmaceutical Chemistry and Applications 16
- Medical Imaging Techniques and Applications 5
Oncology 29
- HER2/EGFR in Cancer Research 20

Co-authors: Helmout Modjtahedi (13 shared papers)S. A. Eccles (11 shared papers)G. Box (7 shared papers)Jennifer A. Leeds (1 shared paper)Steve Hobbs (6 shared papers)M. Rufus Crompton (2 shared papers)Martin Pagé (2 shared papers)Michael J. Tilby (2 shared papers)
Journals: British Journal of Cancer (8 papers)International Journal of Cancer (6 papers)International Journal of Oncology (3 papers)British Journal of Radiology (3 papers)Journal of Immunological Methods (3 papers)
Partner nations: United Kingdom United States Malta

In The Last Decade

Christopher Dean

74 papers receiving 1.5k citations

Peers

Countries citing papers authored by Christopher Dean

Since Specialization

Citations

This map shows the geographic impact of Christopher Dean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Dean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Dean more than expected).

Fields of papers citing papers by Christopher Dean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Dean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Dean. The network helps show where Christopher Dean may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher Dean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Dean Line = papers co-authored together Christopher Dean links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	THE RECEPTOR FOR EGF AND ITS LIGANDS - EXPRESSION, PROGNOSTIC VALUE AND TARGET FOR THERAPY IN CANCER (REVIEW) International Journal of Oncology ·Helmout Modjtahedi, Christopher Dean	1994	119
2	Brk, a Breast Tumor-derived Non-receptor Protein-tyrosine Kinase, Sensitizes Mammary Epithelial Cells to Epidermal Growth Factor Journal of Biological Chemistry ·Tahereh Kamalati, Helen E. Jolin, Philip J. Mitchell, Karen Barker, L. Elizabeth Jackson, Christopher Dean, Martin Pagé, Barry A. Gusterson, M. Rufus Crompton	1996	98
3	Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer British Journal of Cancer ·Helmout Modjtahedi, Tamas Hickish, Margery Nicolson, J. Moore, JM Styles, S. A. Eccles, Elise Jackson, Janine Salter, John Sloane, Loreto Spencer, K. Priest, Isabel Smith Zubiaga, Christopher Dean, M. Gore	1996	82
4	Peptide deformylase as an antibacterial target: a critical assessment Current Opinion in Pharmacology ·Jennifer A. Leeds, Christopher Dean	2006	67
5	Ricin B chain converts a non‐cytotoxic antibody‐ricin A chain conjugate into a potent and specific cytotoxic agent FEBS Letters ·Deirdre P. McIntosh, D. C. Edwards, A.J. Cumber, G.D. Parnell, Christopher Dean, W. C. J. Ross, J.A. Forrester	1983	59
6	Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction British Journal of Cancer ·Helmout Modjtahedi, S. A. Eccles, G. Box, JM Styles, Christopher Dean	1993	58
7	An evaluation of four CT–MRI co-registration techniques for radiotherapy treatment planning of prone rectal cancer patients British Journal of Radiology ·Christopher Dean, Jonathan Sykes, Rachel Cooper, Paul Hatfield, B. Carey, S. Swift, Sarah E. Bacon, David Thwaites, David Sebag‐Montefiore, Ashley M. Morgan	2011	57
8	Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185. PubMed ·Sue Eccles, William Court, Gary Box, Christopher Dean, RG Melton, Caroline J. Springer	1994	56
9	Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor. PubMed ·Helmout Modjtahedi, S. A. Eccles, J Sandle, G. Box, Jenny Titley, Christopher Dean	1994	54
10	Targeting of cells expressing wild‐type EGFR and type‐III mutant EGFR (EGFRvIII) by anti‐EGFR MAb ICR62: A two‐pronged attack for tumour therapy International Journal of Cancer ·Helmout Modjtahedi, David K. Moscatello, Gary Box, Margaret Green, C Shotton, David Lamb, Lesley J. Reynolds, Albert J. Wong, Christopher Dean, Hilary Thomas, Suzanne A. Eccles	2003	53
11	Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in Vitro Virology ·J L Cordell, John P. Moore, Christopher Dean, Per Johan Klasse, Robin A. Weiss, Jane A. McKeating	1991	50
12	Immunological detection of DNA damage caused by melphalan using monoclonal antibodies. PubMed ·Michael J. Tilby, Jennifer M. Styles, Christopher Dean	1987	44
13	Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge. PubMed ·Pamela Dunn, Christine A. Johnson, J M Styles, Shirley Pease, Christopher Dean	1987	44
14	Two erbB-4 transcripts are expressed in normal breast and in most breast cancers Oncogene ·Carol Sawyer, Ian D. Hiles, Martin Pagé, M. Rufus Crompton, Christopher Dean	1998	42
15	Stereotactic Body Radiotherapy in Prostate Cancer: Is Rapidarc a Better Solution than Cyberknife? Clinical Oncology ·Niall MacDougall, Christopher Dean, R. Muirhead	2013	35
16	Plasma Infusions into Porcine Cerebral White Matter Induce Early Edema, Oxidative Stress, Pro-Inflammatory Cytokine Gene Expression and DNA Fragmentation: Implications for White Matter Injury with Increased Blood- Brain-Barrier Permeability Current Neurovascular Research ·Kenneth R. Wagner, Christopher Dean, Shauna Beiler, David R. Bryan, Benjamin Packard, A. George Smulian, Michael J. Linke, Gabrielle M. de Courten‐Myers	2005	35
17	IKKβ–NF-κB signaling in adult chondrocytes promotes the onset of age-related osteoarthritis in mice Science Signaling ·Sarah E. Catheline, Richard D. Bell, Luke S. Oluoch, Marian James, Katherine Escalera-Rivera, Robert Maynard, Martin Chang, Christopher Dean, Elizabeth Botto, John Ketz, Brendan F. Boyce, Michael J. Zuscik, Jennifer H. Jonason	2021	32
18	The chondroitin sulfate proteoglycan NG2 is a tumour-specific antigen on the chemically induced rat chondrosarcoma HSN International Journal of Cancer ·Olivier Léger, Caroline Johnson‐Léger, Elizabeth B. Jackson, Brian Coles, Christopher Dean	1994	29
19	Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production. PubMed ·S M North, J M Styles, Steve Hobbs, Christopher Dean	1982	29
20	Dosimetric characterization of the iBEAM evo carbon fiber couch for radiotherapy Medical Physics ·David W. Smith, D. Christophides, Christopher Dean, M. Naisbit, Joshua Mason, Andrew Morgan	2010	28

About Christopher Dean

Christopher Dean is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Radiation, Immunology and Immunology and Allergy, having authored 78 papers that have together received 1.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (44 papers), HER2/EGFR in Cancer Research (20 papers), Radiopharmaceutical Chemistry and Applications (16 papers), Glycosylation and Glycoproteins Research (13 papers), Advanced Radiotherapy Techniques (9 papers), T-cell and B-cell Immunology (6 papers), Protein purification and stability (5 papers) and Medical Imaging Techniques and Applications (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (656 citations), Oncology (660 citations), Radiation (163 citations), Immunology (285 citations) and Biotechnology (115 citations). Christopher Dean has collaborated with scholars based in United Kingdom, United States and Malta. Frequent co-authors include Helmout Modjtahedi, S. A. Eccles, G. Box, Jennifer A. Leeds, Steve Hobbs, M. Rufus Crompton, Martin Pagé, Michael J. Tilby, Niall MacDougall and R. Muirhead. Their work appears in journals such as British Journal of Cancer, International Journal of Cancer, International Journal of Oncology, British Journal of Radiology and Journal of Immunological Methods.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact